COMPANY

Zata Pharmaceuticals

HQ: Worcester, MA source · zataweb.wordpress.com ↗ · New England

Location: Worcester, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

9NIH grants

NIH awards 9

Annual award amounts. Total $6.2M.

Sep 14, 2021 NIH award 1R43HL158291-01 FY2021: $717,598 awarded for that fiscal year; activity R43 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. Highly Selective Pathogen Inactiva source ↗
Apr 2, 2021 NIH award 5R44HL145783-03 FY2021: $1,169,287 awarded for that fiscal year; activity R44 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. A CLOSED SYSTEM FOR PATHOGEN RED source ↗
Mar 12, 2020 NIH award 4R44HL145783-02 FY2020: $1,010,910 awarded for that fiscal year; activity R44 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. A CLOSED SYSTEM FOR PATHOGEN RED source ↗
Feb 22, 2019 NIH award 1R44HL145783-01 FY2019: $780,492 awarded for that fiscal year; activity R44 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. A CLOSED SYSTEM FOR PATHOGEN REDUC source ↗
Aug 30, 2018 NIH award 1R43GM130187-01 FY2018: $402,225 awarded for that fiscal year; activity R43 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. New-Generation of Fluorescently-La source ↗
May 11, 2017 NIH award 5R44GM109517-03 FY2017: $587,932 awarded for that fiscal year; activity R44 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. SELF-NEUTRALIZING OLIGONUCLEOTIDES source ↗
May 27, 2016 NIH award 2R44GM109517-02 FY2016: $796,420 awarded for that fiscal year; activity R44 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. SELF-NEUTRALIZING OLIGONUCLEOTIDES source ↗
Aug 31, 2015 NIH award 1R43HL125015-01A1 FY2015: $402,588 awarded for that fiscal year; activity R43 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. AZIRIDINYL GROUPS CONTAINING POL source ↗
Sep 3, 2014 NIH award 1R43GM109517-01A1 FY2014: $363,842 awarded for that fiscal year; activity R43 (SBIR); PI TABATADZE, DAVID R; recipient as written: ZATA PHARMACEUTICALS, INC., WORCESTER, MA. SELF-NEUTRALIZING OLIGONUCLEOTID source ↗